Pathological examination of the placenta: Raison d'être, clinical relevance and medicolegal utility

Singapore Medical Journal

Volumn 50, Issue 12, 2009, Pages 1123-1133

  Chang, Kenneth T E ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Medicolegal; Placenta; Placental pathological examination; Poor neonatal outcome

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID;

ACUTE DISEASE; ADVERSE OUTCOME; BIRTH INJURY; BIRTH WEIGHT; BLEEDING; BLOOD VESSEL OCCLUSION; CHORIOAMNIONITIS; CHRONIC DISEASE; CLINICAL FEATURE; CONGENITAL MALFORMATION; CYTOMEGALOVIRUS; DISEASE COURSE; DISEASE SEVERITY; ELECTRON MICROSCOPY; FETUS HYDROPS; FEVER; GESTATIONAL AGE; HEALTH CARE PERSONNEL; HERPES SIMPLEX; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY INFILTRATE; INVASIVE PROCEDURE; MECONIUM; MEDICOLEGAL ASPECT; MULTIPLE PREGNANCY; NEWBORN ASSESSMENT; OBSTETRICS; OLIGOHYDRAMNIOS; ONCOLOGY; OUTCOME ASSESSMENT; PHYSICIAN; PLACENTA; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PLACENTA PERFUSION; PLACENTA VILLUS; PLACENTAL TRANSFER; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURE LABOR; PUERPERAL INFECTION; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RUBELLA; SEIZURE; SEPSIS; SOLUTIO PLACENTAE; STILLBIRTH; STREPTOCOCCUS INFECTION; SYPHILIS; SYSTEMIC DISEASE; THROMBOSIS; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT OUTCOME; UMBILICAL CORD; UMBILICAL MALFORMATION; VASCULAR DISEASE;

FEMALE; HUMANS; LIABILITY, LEGAL; PLACENTA; PLACENTA DISEASES; PREGNANCY; SPECIMEN HANDLING;

EID: 77749292252     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Placental pathology. ACOG committee opinion: committee on gynecologic practice. Number 102 - December 1991. Int J Gynaecol Obstet 1992; 39:146-7.
2. Altshuler G. Role of the placenta in perinatal pathology (revisited). Pediatr Pathol Lab Med 1996; 16:207-33.
3. Langston C, Kaplan C, Macpherson T, et al. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1997; 121:449-76.
4. Manek S, Warren BF. The Multidisciplinary Team (MDT) meeting and the role of pathology. In: Kirkham N, Shepherd NA, eds. Progress in Pathology. Cambridge: Cambridge University Press 2007: 235-46.
5. Roberts DJ, Oliva E. Clinical significance of placental examination in perinatal medicine. J Matern Fetal Neonatal Med 2006; 19:255-64.
6. Baergen RN. Macroscopic examination of the placenta immediately following birth. J Nurse Midwifery 1997; 42:393-402.
7. Salafia CM, Vintzileos AM. Why all placentas should be examined by a pathologist in 1990. Am J Obstet Gynecol 1990; 163(4 Pt 1):1282-93.
8. Spencer MK, Khong TY. Conformity to guidelines for pathologic examination of the placenta. Arch Pathol Lab Med 2003; 127:205-7.
9. Bull AD, Cross SS, James DS, Silcocks PB. Do pathologists have extrasensory perception? BMJ 1991; 303:1604-5.
10. Sun CC, Revell VO, Belli AJ, Viscardi RM. Discrepancy in pathologic diagnosis of placental lesions. Arch Pathol Lab Med 2002; 126:706-9.
11. Khong TY, Gordijn SJ. Quality of placental pathology reports. Pediatr Dev Pathol 2003; 6:54-8.
12. Gugino LJ, Buerger PT, Wactawski-Wende J, Fisher J. Chorioamnionitis: the association between clinical and histological diagnosis. Prim Care Update Ob Gyns 1998; 5:148.
13. Smulian JC, Shen-Schwarz S, Vintzileos AM, Lake MF, Ananth CV. Clinical chorioamnionitis and histologic placental inflammation. Obstet Gynecol 1999; 94:1000-5.
14. Romero R, Salafia CM, Athanassiadis AP, et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 1992; 166:1382-8.
15. Zhang JM, Kraus FT, Aquino TI. Chorioamnionitis: a comparative histologic, bacteriologic, and clinical study. Int J Gynecol Pathol 1985; 4:1-10.
16. Hillier SL, Witkin SS, Krohn MA, et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81:941-8.
17. Redline RW, Faye-Petersen O, Heller D, et al. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6:435-48.
18. Gibbs RS, Roberts DJ. Case records of the Massachusetts General Hospital. Case 27-2007. A 30-year-old pregnant woman with intrauterine fetal death. N Engl J Med 2007; 357:918-25.
19. van Hoeven KH, Anyaegbunam A, Hochster H, et al. Clinical significance of increasing histologic severity of acute inflammation in the fetal membranes and umbilical cord. Pediatr Pathol Lab Med 1996; 16:731-44.
20. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990; 75:622-6.
21. Craver RD, Baldwin VJ. Necrotizing funisitis. Obstet Gynecol 1992; 79:64-70.
22. Redline RW. Clinically and biologically relevant patterns of placental inflammation. Pediatr Dev Pathol 2002; 5:326-8.
23. Russell P. Inflammatory lesions of the human placenta. III. The histopathology of villitis of unknown aetiology. Placenta 1980; 1:227-44.
24. Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993; 143:473-9.
25. Myerson D, Parkin RK, Benirschke K, Tschetter CN, Hyde SR. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr Dev Pathol 2006; 9:257-65.
26. Labarrere CA, Faulk WP. MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology. Transplantation 1990; 50:812-6.
27. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38:1439-46.
28. Becroft DM, Thompson JM, Mitchell EA. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005; 192:264-71.
29. Redline RW, Patterson P. Patterns of placental injury. Correlations with gestational age, placental weight, and clinical diagnoses. Arch Pathol Lab Med 1994; 118:698-701.
30. Redline RW, O'Riordan MA. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Arch Pathol Lab Med 2000; 124:1785-91.
31. Labarrere C, Althabe O. Chronic villitis of unknown aetiology in recurrent intrauterine fetal growth retardation. Placenta 1987; 8:167-73.
32. Redline RW, Abramowsky CR. Clinical and pathologic aspects of recurrent placental villitis. Hum Pathol 1985; 16:727-31.
33. Boog G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008; 136:9-15.
34. Dickson BC. Venous thrombosis: On the history of Virchow's triad. Univ Toronto Med J 2004; 81:166-71.
35. Baergen RN, Malicki D, Behling C, Benirschke K. Morbidity, mortality, and placental pathology in excessively long umbilical cords: retrospective study. Pediatr Dev Pathol 2001; 4:144-53.
36. Ariel I, Anteby E, Hamani Y, Redline RW. Placental pathology in fetal thrombophilia. Hum Pathol 2004; 35:729-33.
37. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7:443-52.
38. DeSa DJ. Intimal cushions in foetal placental veins. J Pathol 1973; 110:347-52.
39. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995; 26:80-5.
40. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1:3-19.
41. Labarrere CA. Acute atherosis. A histopathological hallmark of immune aggression? Placenta 1988; 9:95-108.
42. Naeye RL. Do placental weights have clinical significance? Hum Pathol 1987; 18:387-91.
43. Magid MS, Kaplan C, Sammaritano LR, et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998; 179:226-34.
44. De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980; 87:678-85.
45. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol 2001; 184:946-53.
46. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997; 89:265-71.
47. Naeye RL. Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol 1989; 20:441-4.
48. Harris BA, Jr. Peripheral placental separation: a review. Obstet Gynecol Surv 1988; 43:577-81.
49. Devi B, Jennison RF, Langley FA. Significance of placental pathology in transplacental haemorrhage. J Clin Pathol 1968; 21:322-31.
50. Pearlstone M, Baxi L. Subchorionic hematoma: a review. Obstet Gynecol Surv 1993; 48:65-8.
51. Heller DS, Rush D, Baergen RN. Subchorionic hematoma associated with thrombophilia: report of three cases. Pediatr Dev Pathol 2003; 6:261-4.
52. Shanklin DR, Scott JS. Massive subchorial thrombohaematoma (Breus' mole). Br J Obstet Gynaecol 1975; 82:476-87.
53. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002; 5:159-64.
54. Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med 1996; 16:293-7.
55. Katz VL, DiTomasso J, Farmer R, Carpenter M. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. Am J Perinatol 2002; 19:273-7.
56. Robb JA, Benirschke K, Mannino F, Voland J. Intrauterine latent herpes simplex virus infection: II. Latent neonatal infection. Hum Pathol 1986; 17:1210-7.
57. Vernof KK, Benirschke K, Kephart GM, Wasmoen TL, Gleich GJ. Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome. Am J Obstet Gynecol 1992; 167:1355-63.
58. Naeye RL. Maternal floor infarction. Hum Pathol 1985; 16:823-8.
59. Andres RL, Kuyper W, Resnik R, Piacquadio KM, Benirschke K. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol 1990; 163:935-8.
60. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG 2003; 110:292-5.
61. Khong TY. What's in fibrin? Pediatr Dev Pathol 2002; 5:106-7.
62. Mandsager NT, Bendon R, Mostello D, et al. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol 1994; 83(5 Pt 1):750-4.
63. Fuke Y, Aono T, Imai S, et al. Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Invest 1994; 38:5-9.
64. Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002; 109:570-3.
65. Benirschke K. Placenta pathology questions to the perinatologist. J Perinatol 1994; 14:371-5.
66. Sepkowitz S. Influence of the legal imperative and medical guidelines on the incidence and management of the meconiumstained newborn. Am J Dis Child 1987; 141:1124-7.
67. Nathan L, Leveno KJ, Carmody TJ 3rd, Kelly MA, Sherman ML. Meconium: a 1990s perspective on an old obstetric hazard. Obstet Gynecol 1994; 83:329-32.
68. Greenwood C, Lalchandani S, MacQuillan K, et al. Meconium passed in labor: how reassuring is clear amniotic fluid? Obstet Gynecol 2003; 102:89-93.
69. Meydanli MM, Dilbaz B, Calişkan E, Dilbaz S, Haberal A. Risk factors for meconium aspiration syndrome in infants born through thick meconium. Int J Gynaecol Obstet 2001; 72:9-15.
70. Dye T, Aubry R, Gross S, Artal R. Amnioinfusion and the intrauterine prevention of meconium aspiration. Am J Obstet Gynecol 1994; 171:1601-5.
71. Usta IM, Mercer BM, Aswad NK, Sibai BM. The impact of a policy of amnioinfusion for meconium-stained amniotic fluid. Obstet Gynecol 1995; 85:237-41.
72. Altshuler G, Hyde S. Meconium-induced vasocontraction: a potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome. J Child Neurol 1989; 4:137-42.
73. Altshuler G, Arizawa M, Molnar-Nadasdy G. Meconium-induced umbilical cord vascular necrosis and ulceration: a potential link between the placenta and poor pregnancy outcome. Obstet Gynecol 1992; 79(5 Pt 1):760-6.
74. Miller PW, Coen RW, Benirschke K. Dating the time interval from meconium passage to birth. Obstet Gynecol 1985; 66:459-62.
75. Fujikura T, Klionsky B. The significance of meconium staining. Am J Obstet Gynecol 1975; 121:45-50.
76. Strong TH Jr, Jarles DL, Vega JS, Feldman DB. The umbilical coiling index. Am J Obstet Gynecol 1994; 170(1 Pt 1):29-32.
77. Lacro RV, Jones KL, Benirschke K. The umbilical cord twist: origin, direction, and relevance. Am J Obstet Gynecol 1987; 157(4 Pt 1):833-8.
78. Miller ME, Jones MC, Smith DW. Tension: the basis of umbilical cord growth. J Pediatr 1982; 101:844.
79. Naeye RL. Functionally important disorders of the placenta, umbilical cord, and fetal membranes. Hum Pathol 1987; 18:680-91.
80. Gilbert EF, Zugibe FT. Torsion and constriction of the umbilical cord - a cause of fetal death. Arch Pathol 1974; 97:58-9.
81. Sun Y, Arbuckle S, Hocking G, Billson V. Umbilical cord stricture and intrauterine fetal death. Pediatr Pathol Lab Med 1995; 15:723-32.
82. Benirschke K, Bourne GL. The incidence and prognostic implication of congenital absence of one umbilical artery. Am J Obstet Gynecol 1960; 79:251-4.
83. Mello MM, Studdert DM, Brennan TA. The new medical malpractice crisis. N Engl J Med 2003; 348:2281-4.
84. Scheller JM, Nelson KB. Does cesarean delivery prevent cerebral palsy or other neurologic problems of childhood? Obstet Gynecol 1994; 83:624-30.
85. Winter S, Autry A, Boyle C, Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002; 110:1220-5.
86. Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349:1765-9.
87. Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr 1999; 11:487-91.
88. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med 1994; 330:188-95.
89. Ward CJ. Analysis of 500 obstetric and gynecologic malpractice claims: causes and prevention. Am J Obstet Gynecol 1991; 165:298-304; discussion 304-6.